Corrigendum: Evaluation of cerebrospinal fluid neurofilament light chain levels in multiple sclerosis and non-demyelinating diseases of the central nervous system: clinical and biochemical perspective.
出版信息
Biomol Biomed. 2023 Mar 16;23(2):351. doi: 10.17305/bjbms.2022.8354.
Abstract
摘要
相似文献
1
Corrigendum: Evaluation of cerebrospinal fluid neurofilament light chain levels in multiple sclerosis and non-demyelinating diseases of the central nervous system: clinical and biochemical perspective.勘误：多发性硬化症和中枢神经系统非脱髓鞘疾病中脑脊液神经丝轻链水平的评估：临床和生化视角。
Biomol Biomed. 2023 Mar 16;23(2):351. doi: 10.17305/bjbms.2022.8354.
2
Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome.神经丝轻链和寡克隆带是影像学孤立综合征的预后生物标志物。
Brain. 2018 Apr 1;141(4):1085-1093. doi: 10.1093/brain/awy021.
3
Increased cerebrospinal fluid chitinase 3-like 1 and neurofilament light chain in pediatric acquired demyelinating syndromes.儿童获得性脱髓鞘综合征中脑脊液几丁质酶 3 样蛋白 1 和神经丝轻链增加。
Mult Scler Relat Disord. 2018 Aug;24:175-183. doi: 10.1016/j.msard.2018.05.017. Epub 2018 Jun 11.
4
Evaluation of cerebrospinal fluid neurofilament light chain levels in multiple sclerosis and non-demyelinating diseases of the central nervous system: clinical and biochemical perspective.评估多发性硬化症和中枢神经系统非脱髓鞘疾病中的脑脊液神经丝轻链水平：临床和生化视角。
Bosn J Basic Med Sci. 2022 Sep 16;22(5):699-706. doi: 10.17305/bjbms.2021.7326.
5
Increased cerebrospinal fluid neurofilament light chain in central nervous system inflammatory demyelinating disease.中枢神经系统炎性脱髓鞘疾病患者脑脊液神经丝轻链增加。
Mult Scler Relat Disord. 2019 May;30:123-128. doi: 10.1016/j.msard.2019.02.009. Epub 2019 Feb 8.
6
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis.脑脊液神经丝轻链可预测首次提示多发性硬化的脱髓鞘事件后的疾病活动。
Mult Scler Relat Disord. 2019 Oct;35:228-232. doi: 10.1016/j.msard.2019.07.025. Epub 2019 Jul 27.
7
Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases.测定多发性硬化症和其他神经系统疾病患者脑脊液中的几丁质酶 3 样蛋白 1。
PLoS One. 2020 May 21;15(5):e0233519. doi: 10.1371/journal.pone.0233519. eCollection 2020.
8
Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis.几丁质酶3样蛋白1和神经丝轻链的脑脊液水平可预测视神经炎后多发性硬化症的发展及残疾情况。
Mult Scler. 2015 Dec;21(14):1761-70. doi: 10.1177/1352458515574148. Epub 2015 Feb 19.
9
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation.一种新的脑脊液神经丝轻链酶联免疫吸附测定法：分析验证和临床评估。
Alzheimers Res Ther. 2018 Jan 23;10(1):8. doi: 10.1186/s13195-018-0339-1.
10
Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis.脑脊液中的神经丝轻链与临床孤立综合征及复发缓解型多发性硬化症疾病活动的预测
Eur J Neurol. 2017 May;24(5):703-712. doi: 10.1111/ene.13274. Epub 2017 Mar 6.
本文引用的文献
1
Evaluation of cerebrospinal fluid neurofilament light chain levels in multiple sclerosis and non-demyelinating diseases of the central nervous system: clinical and biochemical perspective.评估多发性硬化症和中枢神经系统非脱髓鞘疾病中的脑脊液神经丝轻链水平：临床和生化视角。
Bosn J Basic Med Sci. 2022 Sep 16;22(5):699-706. doi: 10.17305/bjbms.2021.7326.
Zotero 插件